|
The aquabeam robotic system is a reusable device; therefore it is currently in the possession of the user facility.The investigation of this event consisted of a review of the device history record (dhr), and instructions for use (ifu).A review of the device history record (dhr) for ab2000-d/serial number: (b)(6) was conducted, which confirmed that there were no non-conformance's, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the device met all design and manufacturing specifications when released for distribution.A review of the log files for this procedure could not be conducted as they were not provided.Three good faith efforts (gfe) were made to obtain the log files without success.If the log files are made available in the future, then this complaint will be reopened to conduct such a review.The aquabeam robotic system instructions for use (ifu0101-00), rev.E, was reviewed and states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system¿s intended use.The aquabeam robotic system is a reusable device; therefore, it is still currently in possession of the user facility.It was reported that the patient has a seizure in the post anesthesia care unit (pacu).The treating surgeon believes that the event is attributed to aquablation.The patient had no pre-existing conditions.After patient experienced seizure, patient was admitted to the intensive care unit (icu).The patient had a prolonged hospital stay for 2 additional days.Past medical history of the patient is unavailable.The patient has been discharged since then.No malfunction of the aquabeam robotic system was reported.Based on the event details, plus a review of dhr, and ifu, the root cause of the event could not be established.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|
|
A male patient underwent aquablation therapy for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics inc.(procept) became aware that, post-aquablation therapy, the patient experienced a seizure in the post anesthesia care unit (pacu).According to the treating surgeon, he believes the event is attributed to aquablation.The patient had no pre-existing conditions.After the patient experienced a seizure, the patient was admitted to the intensive care unit (icu).The patient had a prolonged hospital stay for two additional days.The patient has been discharged since then.No malfunction of the aquabeam robotic system was reported.
|